The Fenland Study - Phase 2
Research type
Research Study
Full title
The Fenland Study - Phase 2
IRAS ID
138617
Contact name
Nicholas J Wareham
Contact email
Sponsor organisation
University of Cambridge
Research summary
Type 2 diabetes (T2D) arise from an interaction between lifestyle, genetic and environmental factors. It is projected to be the 7th most common cause of death by 2030. Therefore a better understanding of the causes of this disease is necessary to form effective public health policies. Phase one of the Fenland study allowed us to take a snap shot of participants biological & physical health as well as dietary habits. Phase 2 of the Fenland study will allow us to see any changes in these over time and see how lifestyle, genetic and environmental factors interact over time. All participants from phase 1 who agreed to be re-approached for future research are eligible for phase 2. Participants will undergo a thorough health check at one of our 3 testing facilities in Cambridgeshire. This includes collection of blood samples, an oral glucose tolerance test, height, weight, hip & waist measurements, blood pressure reading, an ECG (electrocardiogram), body fat distribution using ultrasound and Dual Energy X-ray Absorptiometry (DEXA), and a fitness test. Participants will also fill in a questionnaires assessing dietary and activity behaviours, as well as health & lifestyle elements. Following the visit participants will wear physical activity monitors to establish energy expenditure and activity in a free living environment for 7 days. The follow up phase is expected to last up to 5 years.
REC name
East of England - Cambridge East Research Ethics Committee
REC reference
14/EE/0122
Date of REC Opinion
24 Apr 2014
REC opinion
Favourable Opinion